Phase 2/3 Trial of Anavex 2-73 Enrolling Girls in Canada, Australia

Phase 2/3 Trial of Anavex 2-73 Enrolling Girls in Canada, Australia

308635

Phase 2/3 Trial of Anavex 2-73 Enrolling Girls in Canada, Australia

A clinical trial evaluating oral Anavex 2-73 in children and teenagers with Rett syndrome is recruiting up to 84 girls, ages 5 to 17, at a center in Vancouver, Canada, and three sites in Australia. According to a press release from the Ontario Rett Syndrome Association, the British Columbia Children’s Hospital site marks the first Rett syndrome trial in Canada. The Phase 2/3 study (NCT04304482), called EXCELLENCE, will run for 12 weeks with patients randomly assigned in a 2:3…

You must be logged in to read/download the full post.